The present invention relates to compounds of formula (I):
wherein R1, R2, R3, R4, X1, X2, X3 and Z are as defined in claim 1.
The compounds are useful in the prevention and/or treatment of bacterial infections.
本发明涉及式(I)化合物:
其中 R1、R2、R3、R4、X1、X2、X3 和 Z 如权利要求 1 所定义。
这些化合物可用于预防和/或治疗细菌感染。
US6534651B2
申请人:——
公开号:US6534651B2
公开(公告)日:2003-03-18
[EN] LIQUID CRYSTAL ALIGNING AGENT, LIQUID CRYSTAL ALIGNMENT FILM, AND LIQUID CRYSTAL DISPLAY ELEMENT<br/>[FR] AGENT D'ALIGNEMENT DE CRISTAUX LIQUIDES, FILM D'ALIGNEMENT DE CRISTAUX LIQUIDES, ET ÉLÉMENT D'AFFICHAGE À CRISTAUX LIQUIDES
[EN] COMPOSITIONS, METHODS AND KITS FOR DETECTING MELANOMA AND MARGINS OF MELANOMA<br/>[FR] COMPOSITIONS, PROCÉDÉS ET NÉCESSAIRES DE DÉTECTION DE MÉLANOME ET DE CONTOURS DE MÉLANOME
申请人:UNIV MIAMI
公开号:WO2012040318A2
公开(公告)日:2012-03-29
Described herein are compositions, methods and kits for detection of melanoma and determination of melanoma margins. The present invention relates to a novel panel of volatile metabolic biomarkers that can be used in the diagnosis of melanoma skin cancer. A novel approach to detect melanoma is based on volatile by-products of altered cancer metabolism. This invention further provides a method for identifying molecules useful in the detection of melanoma and sets a foundation for development of a non-invasive detection technology, a biosensor, for melanoma diagnosis. Uses for this technology include a diagnostic screen that will help clinicians to assess this disease. One advantage provided by the compositions, methods and kits described herein is that metabolites are at the end phase of the genome-transciptome-proteome-metabolome cascade and thus are the most predictive of the cancer phenotype.
[EN] METHODS AND COMPOSITIONS FOR THE TREATMENT OF RNA VIRAL INFECTIONS<br/>[FR] MÉTHODES ET COMPOSITIONS POUR LE TRAITEMENT D'INFECTIONS VIRALES À ARN
申请人:UNIV CALIFORNIA
公开号:WO2018075947A1
公开(公告)日:2018-04-26
Disclosed herein, inter alia, are agents having antiviral activity and methods of use thereof.